Inventor · disambiguated record
Stuart B. Levy
Also filed as: LEVY STUART · LEVY STUART B
36 granted patents·39 pending applications·1,108 citations·filing 1982–2024
98Inventor score
Top patents by PatentIndex Score
75 records- 0198US6818634B27-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compoundsPARATEK PHARM INNC·Filed 2001·Granted Nov 16, 2004·130 cites·81 claims
- 0297US6833365B2Tetracycline compounds for treatment of Cryptosporidium parvum related disordersTUFTS COLLEGE·Filed 2001·Granted Dec 21, 2004·92 cites·38 claims
- 0396US7414041B2Reducing tetracycline resistance in living cellsTUFTS COLLEGE·Filed 2004·Granted Aug 19, 2008·34 cites·17 claims
- 0495US7202235B2Tetracycline compounds for treatment of cryptosporidium parvum related disordersTUFTS COLLEGE·Filed 2004·Granted Apr 10, 2007·56 cites·57 claims
- 0595US5021407ATetracycline activity enhancementTUFTS COLLEGE·Filed 1986·Granted Jun 4, 1991·88 cites·12 claims
- 0692US7405235B2Transcription factor modulating compounds and methods of use thereofPARATEK PHARM INNC·Filed 2003·Granted Jul 29, 2008·41 cites·187 claims
- 0791US6448006B1Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solventsTUFTS COLLEGE·Filed 2000·Granted Sep 10, 2002·26 cites·22 claims
- 0891US6346391B1Methods of reducing microbial resistance to drugsTUFTS COLLEGE·Filed 1999·Granted Feb 12, 2002·75 cites·24 claims
- 0991US5589470AReducing tetracycline resistance in living cellsTUFTS COLLEGE·Filed 1992·Granted Dec 31, 1996·72 cites·27 claims
- 1090US9562003B2Methods of using substituted tetracycline compounds to modulate RNAPARATEK PHARM INNC·Filed 2015·Granted Feb 7, 2017·7 cites·10 claims
- 1190US5811412AReducing tetracycline resistance in living cellsTUFTS COLLEGE·Filed 1996·Granted Sep 22, 1998·79 cites·28 claims
- 1289US6756365B2Reducing tetracycline resistance in living cellsTUFTS COLLEGE·Filed 2000·Granted Jun 29, 2004·16 cites·16 claims
- 1388US7935687B2Methods for treating spinal muscular atrophy using tetracycline compoundsPARATEK PHARM INNC·Filed 2008·Granted May 3, 2011·11 cites·63 claims
- 1484US4806529ATetracycline activity enhancementTUFTS COLLEGE·Filed 1982·Granted Feb 21, 1989·48 cites·2 claims
- 1583US7075582B2Methods for identifying and using MarR family polypeptide binding compoundsPARATEK PHARM INNC·Filed 2002·Granted Jul 11, 2006·10 cites·7 claims
- 1682US8399437B2Methods for treating spinal muscular atrophy using tetracycline compoundsBERNIAC JOEL·Filed 2011·Granted Mar 19, 2013·7 cites·18 claims
- 1782US5258372ATetracycline activity enhancement using doxycycline or sancyclineTUFTS COLLEGE·Filed 1991·Granted Nov 2, 1993·55 cites·3 claims
- 1880US7026136B2Methods of reducing microbial resistance to drugsTUFTS COLLEGE·Filed 2003·Granted Apr 11, 2006·10 cites·27 claims
- 1980US6677133B2Methods of reducing microbial resistance to drugsTUFTS COLLEGE·Filed 2001·Granted Jan 13, 2004·12 cites·29 claims
- 2078US7202339B2Crystals of MarR polypeptides, regulators of multiple antibiotic resistanceUNIV BOSTON·Filed 2002·Granted Apr 10, 2007·8 cites·10 claims
- 2177US8012711B2Methods of screening for compounds that reduce microbial resistance to fluoroquinolonesTUFTS COLLEGE·Filed 2009·Granted Sep 6, 2011·1 cites·13 claims
- 2277US5889866AMethod and apparatus for controlling access to detachably connectable computer devices using an encrypted passwordINTEL CORP·Filed 1996·Granted Mar 30, 1999·102 cites·15 claims
- 2377US5817793AMultiple antibiotic resistance operon assaysTUFTS COLLEGE·Filed 1994·Granted Oct 6, 1998·34 cites·27 claims
- 2476US8048906B2Optically pure and enriched isomers of chelating ligands and contrast agentsCATALYST MEDICAL·Filed 2006·Granted Nov 1, 2011·3 cites·33 claims
- 2575US7807660B2Tetracycline compounds for treatment of Cryptosporidium parvum related disordersTUFTS COLLEGE·Filed 2007·Granted Oct 5, 2010·1 cites·23 claims
- 2674US6068972AMethods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solventsTUFTS COLLEGE·Filed 1997·Granted May 30, 2000·18 cites·6 claims
- 2773US8039221B2Methods for identifying and using MarR family polypeptide binding compoundsPARATEK PHARM INNC·Filed 2009·Granted Oct 18, 2011·0 cites·12 claims
- 2873US2011230523A1Transcription factor modulating compounds and methods of use thereofPARATEK PHARM INNC·Filed 2009·Application pending·0 cites
- 2971US8173624B2Methods of using substituted tetracycline compounds to modulate RNALEVY STUART B·Filed 2003·Granted May 8, 2012·6 cites·17 claims
- 3071US2025041033A1Customized pads and related methods for dental appliancesLEVY STUART·Filed 2024·Application pending·0 cites
- 3171US2010227850A1Methods for preventing and treating microbial infections by modulating transcription factorsPARATEK PHARM INNC·Filed 2009·Application pending·0 cites
- 3270US2005136460A1Multiple antibiotic resistance operon assaysFiled 2004·Application pending·0 cites
- 3369US5064821AMethod and compositions for overcoming tetracycline resistance within living cellsTUFTS COLLEGE·Filed 1990·Granted Nov 12, 1991·31 cites·13 claims
- 3468US6485973B1Oligonucleotides specific for the marORAB operonHYBRIDON INC·Filed 2000·Granted Nov 26, 2002·1 cites·21 claims
- 3567US2015141381A1Tetracycline compounds having target therapeutic activitiesPARATEK PHARM INNC·Filed 2014·Application pending·0 cites
- 3666US5650321AIdentification and isolation of new genes of a bacterial multiple antibiotic resistance regulonTUFTS COLLEGE·Filed 1995·Granted Jul 22, 1997·13 cites·13 claims
- 3766US2010292091A1Mara family helix-turn-helix domains and their methods of useTUFTS COLLEGE·Filed 2009·Application pending·0 cites
- 3865US2006194773A1Tetracyline compounds having target therapeutic activitiesPARATEK PHARM INNC·Filed 2004·Application pending·0 cites
- 3965US2006264517A1Methods of reducing microbial resistance to drugsTUFTS COLLEGE·Filed 2005·Application pending·0 cites
- 4064US7732429B2Reducing tetracycline resistance in living cellsTUFTS COLLEGE·Filed 2008·Granted Jun 8, 2010·0 cites·16 claims
- 4164US2004229243A1MarA family helix-turn-helix domains and their methods of useTUFTS COLLEGE·Filed 2003·Application pending·0 cites
- 4262US5766924AIdentification and isolation of new genes of a bacterial multiple antibiotic resistance regulonTUFTS COLLEGE·Filed 1997·Granted Jun 16, 1998·10 cites·3 claims
- 4362US2019040001A1Methods of using substituted tetracycline compounds to modulate rnaPARATEK PHARM INNC·Filed 2018·Application pending·0 cites
- 4462US2018016225A1Tetracycline compounds having target therapeutic activitiesPARATEK PHARM INNC·Filed 2017·Application pending·0 cites
- 4562US2014343020A1Methods of using substituted tetracycline compounds to modulate rnaPARATEK PHARM INNC·Filed 2014·Application pending·0 cites
- 4662US2006084678A1Methods for identifying and using MarR family polypeptide binding compoundsPARATEK PHARM INNC·Filed 2005·Application pending·0 cites
- 4761US2010298540A1Crystal Structure of a MarR Family PolypeptideTUFTS COLLEGE·Filed 2009·Application pending·0 cites
- 4861US2003171317A1Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solventsTUFTS COLLEGE·Filed 2002·Application pending·0 cites
- 4961US2012209003A1METHODS FOR IDENTIFYING AND USING MarR FAMILY POLYPEPTIDE BINDING COMPOUNDSALEKSHUN MICHAEL N·Filed 2011·Application pending·0 cites
- 5059US2025221997A1Tyk2 inhibitor formulations and methods of making the sameTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stuart B. Levy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →